药物诱导的牙扩大 - - 氨酸:概述和病例报告
Nipun Dhalla1, Lipika Gopal1, Pooja Palwankar1
1Department of Periodontology, Manav Rachna Dental College, SDS, MRIIRS, Q Block, Faridabad 121001, Haryana, India.
Journal of surgical case reports
|May 30, 2024
概括
药物诱导的牙扩大是药物副作用,如的芬伊托因,导致严重的口腔健康问题. 本综述探讨了这种疾病背后的临床,微生物学和外科手术机制.
科学领域:
- 牙科医学 牙科医学
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 牙扩大是各种药物的已知的副作用,包括免疫抑制剂,抗药和通道阻塞剂.
- 是一种流行的神经疾病,在富裕国家影响大约1%的人口.
- 类药物是一种常见的药物,与明显的牙扩大有关,影响言语,和饮食.
研究的目的:
- 阐明药物诱导的牙扩大的机制.
- 提供对这种疾病的临床,微生物学和手术方面的全面概述.
主要方法:
- 药物诱导的牙扩张的文献综述.
- 临床表现的分析.
- 检查微生物学的因素.
- 管理的外科考虑.
主要成果:
- 药物诱导的牙扩大是一种由斑块和结石加剧的炎症反应.
- 牙卫生不佳,运动协调障碍或身体障碍的个人面临更高的风险.
- 这种情况带来了重大的功能和美学挑战.
结论:
- 了解药物诱导的牙扩大多方面的机制对于有效的管理至关重要.
- 本综述强调了药物,口腔卫生和牙周健康之间的相互作用.
更多相关视频
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
171
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
171
Antiepileptic Drugs: Sodium Channel Blockers
511
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
511
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Nonlinear Pharmacokinetics: Causes of Nonlinearity
172
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
172
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Nonlinear Pharmacokinetics: Overview
352
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
352


